Systematic bibliometric and visualized analysis of global research trends, impact, emerging areas, and hotspots of artificial intelligence in personalized medicine.
{"title":"Systematic bibliometric and visualized analysis of global research trends, impact, emerging areas, and hotspots of artificial intelligence in personalized medicine.","authors":"Arwa M Al-Dekah","doi":"10.1007/s00210-025-04732-5","DOIUrl":null,"url":null,"abstract":"<p><p>Artificial intelligence (AI) and machine learning (ML) have significantly impacted the field of medicine. An increasing amount of evidence supports their use in personalized medicine research. This trend necessitates a thorough review of the growing literature to assist researchers in understanding the subject. This study aims to comprehensively analyze and systematically chart the research trends, influence, emerging areas, and key hotspots related to AI and ML in personalized medicine literature. The bibliometric and visualized analysis was conducted systematically using the data taken from the Scopus database. Bibliometric indicators were assessed using Microsoft Excel 365, VOSviewer, and the Bibliometrix R package. A total of 3719 articles were identified, accumulating 88,351 citations with a 42.1% annual growth rate. The yearly publication findings reveal notable upward trends over the last 19 years, peaking in 2024. The USA led in publication volume (38.8%). Harvard Medical School was a top institution. Leading researchers in this field are Michael R. Kosorok (20 articles). Journal of Personalized Medicine ranks highest among articles (69 articles). The authors' keyword analysis identified \"deep learning,\" \"biomarkers,\" and \"radiomics\" as hot research topics. The field of personalized medicine is moving revolutionarily, with AI and ML solutions paving their way and resulting in more research collaboration globally and advancing methodologies at a rapid pace. This study offers a broad knowledge framework, emphasizing significant developments and future directions. The findings offer valuable insights for researchers, policymakers, and funding bodies to support interdisciplinary collaborations and future innovation in AI-driven personalized healthcare.</p>","PeriodicalId":18876,"journal":{"name":"Naunyn-Schmiedeberg's archives of pharmacology","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Naunyn-Schmiedeberg's archives of pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00210-025-04732-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Artificial intelligence (AI) and machine learning (ML) have significantly impacted the field of medicine. An increasing amount of evidence supports their use in personalized medicine research. This trend necessitates a thorough review of the growing literature to assist researchers in understanding the subject. This study aims to comprehensively analyze and systematically chart the research trends, influence, emerging areas, and key hotspots related to AI and ML in personalized medicine literature. The bibliometric and visualized analysis was conducted systematically using the data taken from the Scopus database. Bibliometric indicators were assessed using Microsoft Excel 365, VOSviewer, and the Bibliometrix R package. A total of 3719 articles were identified, accumulating 88,351 citations with a 42.1% annual growth rate. The yearly publication findings reveal notable upward trends over the last 19 years, peaking in 2024. The USA led in publication volume (38.8%). Harvard Medical School was a top institution. Leading researchers in this field are Michael R. Kosorok (20 articles). Journal of Personalized Medicine ranks highest among articles (69 articles). The authors' keyword analysis identified "deep learning," "biomarkers," and "radiomics" as hot research topics. The field of personalized medicine is moving revolutionarily, with AI and ML solutions paving their way and resulting in more research collaboration globally and advancing methodologies at a rapid pace. This study offers a broad knowledge framework, emphasizing significant developments and future directions. The findings offer valuable insights for researchers, policymakers, and funding bodies to support interdisciplinary collaborations and future innovation in AI-driven personalized healthcare.
人工智能(AI)和机器学习(ML)对医学领域产生了重大影响。越来越多的证据支持它们在个性化医学研究中的应用。这种趋势需要对越来越多的文献进行彻底的回顾,以帮助研究人员了解这一主题。本研究旨在全面分析和系统绘制个性化医学文献中AI和ML相关的研究趋势、影响、新兴领域和重点热点。利用Scopus数据库中的数据进行文献计量学和可视化分析。使用Microsoft Excel 365、VOSviewer和Bibliometrix R软件包对文献计量指标进行评估。共收录论文3719篇,累计引用88351次,年增长率42.1%。这份年度报告揭示了过去19年的显著上升趋势,并在2024年达到峰值。美国在出版物数量上领先(38.8%)。哈佛医学院是一所顶尖学府。该领域的主要研究者是Michael R. Kosorok(20篇文章)。《Journal of Personalized Medicine》在文章中排名最高(69篇)。作者通过关键词分析,将“深度学习”、“生物标志物”和“放射组学”确定为热门研究课题。个性化医疗领域正在发生革命性的变化,人工智能和机器学习解决方案为其铺平了道路,并在全球范围内带来了更多的研究合作,并迅速推进了方法。本研究提供了一个广泛的知识框架,强调了重要的发展和未来的方向。研究结果为研究人员、政策制定者和资助机构提供了宝贵的见解,以支持人工智能驱动的个性化医疗保健领域的跨学科合作和未来创新。
期刊介绍:
Naunyn-Schmiedeberg''s Archives of Pharmacology was founded in 1873 by B. Naunyn, O. Schmiedeberg and E. Klebs as Archiv für experimentelle Pathologie und Pharmakologie, is the offical journal of the German Society of Experimental and Clinical Pharmacology and Toxicology (Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie, DGPT) and the Sphingolipid Club. The journal publishes invited reviews, original articles, short communications and meeting reports and appears monthly. Naunyn-Schmiedeberg''s Archives of Pharmacology welcomes manuscripts for consideration of publication that report new and significant information on drug action and toxicity of chemical compounds. Thus, its scope covers all fields of experimental and clinical pharmacology as well as toxicology and includes studies in the fields of neuropharmacology and cardiovascular pharmacology as well as those describing drug actions at the cellular, biochemical and molecular levels. Moreover, submission of clinical trials with healthy volunteers or patients is encouraged. Short communications provide a means for rapid publication of significant findings of current interest that represent a conceptual advance in the field.